Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6307213rdf:typepubmed:Citationlld:pubmed
pubmed-article:6307213lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:6307213lifeskim:mentionsumls-concept:C1521747lld:lifeskim
pubmed-article:6307213lifeskim:mentionsumls-concept:C0806987lld:lifeskim
pubmed-article:6307213lifeskim:mentionsumls-concept:C0205282lld:lifeskim
pubmed-article:6307213lifeskim:mentionsumls-concept:C0205183lld:lifeskim
pubmed-article:6307213pubmed:issue8lld:pubmed
pubmed-article:6307213pubmed:dateCreated1983-8-26lld:pubmed
pubmed-article:6307213pubmed:abstractTextThe mononuclear cell infiltrate in benign and malignant breast tissue was studied using monoclonal antibodies with an immunoenzymatic technique. Infiltrating duct carcinomas contained a mononuclear cell infiltrate made up mostly of T lymphocytes, with minor B-cell and macrophage populations. The most preponderant T-cell subset was the T8, cytotoxic-suppressor cell. Some tumors contained T6-positive cells, possibly immature T cells. In contrast, stromal lymphocytes in benign fibrous mastopathy were largely T cells, but the T4, helper-inducer cell was the most preponderant, and T6 cells were not detected. Intraepithelial lymphocytes were identified in benign breast tissue. Intraepithelial lymphocytes are T cells, with a great preponderance of the T8 phenotype. The T6-positive cells were also identified within the epithelium, but they seemed to represent myoepithelial cells rather than immature T cells.lld:pubmed
pubmed-article:6307213pubmed:languageenglld:pubmed
pubmed-article:6307213pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6307213pubmed:citationSubsetAIMlld:pubmed
pubmed-article:6307213pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6307213pubmed:statusMEDLINElld:pubmed
pubmed-article:6307213pubmed:monthAuglld:pubmed
pubmed-article:6307213pubmed:issn0003-9985lld:pubmed
pubmed-article:6307213pubmed:authorpubmed-author:GiornoRRlld:pubmed
pubmed-article:6307213pubmed:issnTypePrintlld:pubmed
pubmed-article:6307213pubmed:volume107lld:pubmed
pubmed-article:6307213pubmed:ownerNLMlld:pubmed
pubmed-article:6307213pubmed:authorsCompleteYlld:pubmed
pubmed-article:6307213pubmed:pagination415-7lld:pubmed
pubmed-article:6307213pubmed:dateRevised2005-11-17lld:pubmed
pubmed-article:6307213pubmed:meshHeadingpubmed-meshheading:6307213-...lld:pubmed
pubmed-article:6307213pubmed:meshHeadingpubmed-meshheading:6307213-...lld:pubmed
pubmed-article:6307213pubmed:meshHeadingpubmed-meshheading:6307213-...lld:pubmed
pubmed-article:6307213pubmed:meshHeadingpubmed-meshheading:6307213-...lld:pubmed
pubmed-article:6307213pubmed:meshHeadingpubmed-meshheading:6307213-...lld:pubmed
pubmed-article:6307213pubmed:meshHeadingpubmed-meshheading:6307213-...lld:pubmed
pubmed-article:6307213pubmed:meshHeadingpubmed-meshheading:6307213-...lld:pubmed
pubmed-article:6307213pubmed:meshHeadingpubmed-meshheading:6307213-...lld:pubmed
pubmed-article:6307213pubmed:meshHeadingpubmed-meshheading:6307213-...lld:pubmed
pubmed-article:6307213pubmed:meshHeadingpubmed-meshheading:6307213-...lld:pubmed
pubmed-article:6307213pubmed:meshHeadingpubmed-meshheading:6307213-...lld:pubmed
pubmed-article:6307213pubmed:meshHeadingpubmed-meshheading:6307213-...lld:pubmed
pubmed-article:6307213pubmed:meshHeadingpubmed-meshheading:6307213-...lld:pubmed
pubmed-article:6307213pubmed:year1983lld:pubmed
pubmed-article:6307213pubmed:articleTitleMononuclear cells in malignant and benign human breast tissue.lld:pubmed
pubmed-article:6307213pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6307213lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6307213lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6307213lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6307213lld:pubmed